TIMP-3 as a Therapeutic Target for Cancer

Therapeutic Advances in Medical Oncology- United States

doi 10.1177/1758835919864247

Full Text

Abstract

Available in

Categories

Oncology

Date

Authors

Publisher

SAGE Publications

Related search

Analysis of Tim-3 as a Therapeutic Target in Prostate Cancer

Tumor Biology
MedicineCancer Research
2017English

The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

ICOS-L as a Potential Therapeutic Target for Cancer Immunotherapy

Current Protein and Peptide Science
MedicineBiochemistryCell BiologyMolecular Biology
2018English

EP4 as a Therapeutic Target for Aggressive Human Breast Cancer

2018English

DNA Methylation as a Therapeutic Target in Cancer

Clinical Cancer Research
Cancer ResearchOncology
2007English

LINE-1 as a Therapeutic Target for Castration-Resistant Prostate Cancer

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Identification of DEK as a Potential Therapeutic Target for Neuroendocrine Prostate Cancer

Oncotarget
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy